Gimv’s Investment In Apraxon Group

Simmons & Simmons has advised Gimv on the deal.

Gimv invested in Apraxon Group, a leading homecare provider group in Germany. Gimv is a European investment company with approximately EUR 2 billion of assets under management.

This is the latest deal where Simmons’ Munich team has advised Gimv on a private equity transaction. Other recent matters include advising Köberl Group, a Gimv portfolio company, on the acquisition of 089 Immobilienmanagement in late 2020.

Apraxon offers high-quality wound care for people with chronic wounds. The company connects patients, medical doctors, nursing services providers/homes and health insurance companies. This investment marks Gimv’s 23rd interest in companies in the healthcare and life sciences sector. 

On its investment in Apraxon, Gimv was advised by a team led by Munich private equity partner Dr Fabian von Samson-Himmelstjerna (Picture). 

 

Involved fees earner: Fabian von Samson-Himmelstjerna – Simmons & Simmons;

Law Firms: Simmons & Simmons;

Clients: Gimv NV;

Author: Federica Tiefenthaler